Diagnostic Model for In-Hospital Bleeding in Patients with Acute ST-Segment Elevation Myocardial Infarction:
1Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
JMIR Medical Informatics
|August 16, 2020
Summary
This study developed and validated a diagnostic model to predict in-hospital bleeding in patients with ST-segment elevation myocardial infarction (STEMI). Advanced age and Killip classification were key predictors, aiding risk assessment for better patient outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Diagnostics
Background:
- Bleeding complications in acute ST-segment elevation myocardial infarction (STEMI) are linked to adverse outcomes.
- Predicting and managing in-hospital bleeding is crucial for STEMI patient care.
Purpose of the Study:
- To develop a diagnostic model for predicting in-hospital bleeding in STEMI patients.
- To externally validate the developed diagnostic model using independent datasets.
Main Methods:
- Multivariate logistic regression analysis of a large cohort of hospitalized STEMI patients (n=4262 for development, n=6015 for validation).
- Identification of risk factors including age and Killip classification.
- Construction of a nomogram and assessment of model performance using discrimination, calibration, and decision curve analysis (DCA).
Main Results:
- In-hospital bleeding occurred in 2.6% of the development cohort and 1.9% of the validation cohort.
- Advanced age (OR 1.047) and high Killip classification (III: OR 3.265, IV: OR 5.133) were significant predictors.
- The diagnostic model demonstrated satisfactory performance with an AUC of 0.777 in the development set and 0.723 in the validation set.
Conclusions:
- A reliable diagnostic model for in-hospital bleeding in STEMI patients was successfully developed and validated.
- The model, incorporating age and Killip classification, aids in predicting bleeding risk.
- The validated model shows potential for improving clinical decision-making and patient management in STEMI.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
122
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
122
Acute Coronary Syndrome I: Introduction
499
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
499
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
266
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
266
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
653
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
653


